Evidence map›Paper›PMID 29363722›Full record

ArticleMolecular medicine reports2018

Therapeutic effects of β-elemene via attenuation of the Wnt/β-catenin signaling pathway in cervical cancer cells.

Lufang Wang, Yanyan Zhao, Qiong Wu, Yifu Guan, Xin Wu

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 35 citations in OpenAlex.

  1. Chinese herbal medicines · 2025
    Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Disease markers · 2022
    Article
  11. Review
  12. Review
  13. Article
  14. Intelligent Diagnosis of Cervical Cancer Based on Data Mining Algorithm.Computational and mathematical methods in medicine · 2021
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Lufang WangDepartment of Gynecology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110000, P.R. China.
Yanyan ZhaoDepartment of Gynecology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110000, P.R. China.
Qiong WuDepartment of Gynecology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110000, P.R. China.
Yifu GuanDepartment of Biochemistry and Molecular Biology, China Medical University, Shenyang, Liaoning 110000, P.R. China.
Xin WuDepartment of Gynecology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110000, P.R. China.
China Medical University · CNFirst Hospital of China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Concurrent radio chemotherapy treatment prolongs the survival rate of patients with advanced cervical cancer; however, it has adverse side‑effects. β‑elemene, an active component of the traditional Chinese medicinal herb Curcuma zedoaria, is a promising alternative therapeutic drug for the treatment of advanced cervical cancer. The aim of the present study was to investigate the antitumor effects of β‑elemene in human cervical cancer SiHa cells and to determine its underlying therapeutic molecular mechanisms. Cell viability, cell cycle progression and apoptosis were detected using an MTT assay and flow cytometry analysis. Furthermore, the levels of cell migration and cell invasion were investigated using Transwell and wound healing assays. The expression levels of Cyclin‑dependent kinase inhibitor 2B (P15), Cyclin D1, cellular tumor antigen p53, apoptosis regulator Bcl‑2 (Bcl‑2), apoptosis regulator BAX (Bax), 72 kDa type IV collagenase (MMP‑2), matrix metalloproteinase‑9 (MMP‑9), β‑catenin, transcription factor 7 (TCF7), and Myc proto‑oncogene protein (c‑Myc) were analyzed via western blotting. The results revealed that β‑elemene inhibited the proliferation of SiHa cells in a dose and time‑dependent manner. Administration of β‑elemene induced G1 phase cell‑cycle arrest, as demonstrated by the upregulation of P15 expression and the downregulation of Cyclin D1 expression. Furthermore, the present study revealed that β‑elemene induced apoptosis in SiHa cells by enhancing the expression of p53 and Bax, and suppressing the expression of Bcl‑2. In addition, treatment with β‑elemene inhibited cell migration and invasion via downregulation of MMP‑2 and MMP‑9 expression levels. Western blotting demonstrated that β‑elemene reduced the expression levels of β‑catenin and its downstream target molecule TCF7, thus resulting in reduced levels of their target proteins, including c‑Myc, Cyclin D1, Bax and MMP‑2 in cervical cancer cells. The results of the present study suggested that β‑elemene may inhibit cell proliferation and invasion, in addition to inducing apoptosis, via attenuation of the Wnt/β‑catenin signaling pathway in cervical cancer cells.

Indexed as

Gene Expression Regulation, NeoplasticAntineoplastic Agents, PhytogenicApoptosisbcl-2-Associated X Proteinbeta CateninCell Line, TumorCell MovementCell ProliferationCurcumaCyclin D1Cyclin-Dependent Kinase Inhibitor p15Drugs, Chinese HerbalG1 Phase Cell Cycle CheckpointsHeLa CellsHumansMatrix Metalloproteinase 2Antineoplastic Agents, PhytogenicBAX protein, humanbcl-2-Associated X ProteinBCL2 protein, humanbeta Cateninbeta-elemeneCCND1 protein, humanCDKN2B protein, humanCTNNB1 protein, humanCyclin D1Cyclin-Dependent Kinase Inhibitor p15Drugs, Chinese HerbalMatrix Metalloproteinase 2Matrix Metalloproteinase 9MMP2 protein, humanMMP9 protein, humanMYC protein, humanProto-Oncogene Proteins c-bcl-2Proto-Oncogene Proteins c-mycSesquiterpenesT Cell Transcription Factor 1TCF7 protein, humanTumor Suppressor Protein p53apoptosiscervical cancerinvasionproliferationWnt/β-cateninβ-elemene

Identifiers

PMID29363722
PMCPMC5802201
OpenAlexW2786587310

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.